Navigation Links
Study Finds Starion Instruments' Tissue Welding Technology Reduces Pain and Bleeding in Tonsillectomy Patients
Date:11/6/2007

Technology may improve quality of recovery compared with cold dissection

procedure

SUNNYVALE, Calif., Nov. 6 /PRNewswire/ -- Starion Instruments, a leading surgical device company, today announced that a study published in the Annals of Otology, Rhinology & Laryngology found that the use of Starion's proprietary Tissue Welding Technology in total tonsillectomy patients resulted in significantly less intraoperative blood loss and lower pain scores compared with cold dissection tonsillectomy.

The study, Thermal Welding Versus Cold Dissection Tonsillectomy: A Prospective, Randomized, Single-Blind Study in Adult Patients, was led by Pelagia Stavroulaki, MD, PhD, Department of Otorhinolaryngology, General Hospital, Volos, Greece. Stavroulaki and her team compared the rates of post-operative morbidity in adults undergoing thermal (tissue) welding tonsillectomy versus cold dissection tonsillectomy. While tonsillectomies are one of the most common surgical procedures, morbidity, mainly hemorrhage and postoperative pain, remains high in the adult population.

The researchers randomized 32 adults with recurrent tonsillitis who were scheduled for elective tonsillectomy to the tissue welding technique or the cold dissection technique, with 16 patients in each group. They estimated intraoperative blood loss by measuring the amount in the suction bottle and by weighing the cotton pledgets before and after the procedures. The patients were discharged the day after surgery with an acetaminophen prescription for pain control and a chart to record the following factors on a daily basis for 10 days following surgery: intensity of post-operative pain, total analgesic requirements, last day of taking analgesics, and any other adverse events.

Stavroulaki and her team found that the rate of intraoperative blood loss was significantly lower in the tissue welding group (p < .0001), with essentially no intraoperative bleeding ob
'/>"/>

SOURCE Starion Instruments
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Texas , Jan. 15, 2014  Humberto C. Antunes,  ... Achievement Award" from the Journal of Drugs in ... & Clinical Conference (ODAC). The event is January 17-20, 2014, at ... Florida . The ODAC is ...
(Date:1/15/2014)...  Manufacturers, suppliers and distributors of innovative medical-related products ... most important business assets, intellectual property (IP). ... Because of the highly-competitive nature of the Medical ... most litigious industry sectors of cases involving IP ...
(Date:1/15/2014)... , Jan. 15, 2014 Tegra Medical is very pleased ... as its new Chief Executive Officer.  Mark was promoted ... he has overseen the company,s four facilities in ... Rica.  Mr. King joined Tegra Medical in 2012 with 20+ ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Intellectual Property Insurance for Medical-related Products and Services 2Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3
... for Cinryze for Acute HAE Indication is June 3, 2009 ... Incorporated (Nasdaq: VPHM ) today announced that the ... for Cinryze C1 Inhibitor (human) as a treatment for acute ... Application (sBLA), submitted to the FDA on December 1, ...
... CVS Caremark Proactive Pharmacy Care approach designed to help ... costs WOONSOCKET, R.I., Feb. 3 /PRNewswire/ ... (NYSE: CVS ) found that nearly half ... adherent to recommended drug therapies, significantly increasing their risk ...
Cached Medicine Technology:FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 2FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 3FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 4FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 5FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 6CVS Caremark Study Finds Non-Adherent Heart Failure Patients Almost Twice as Likely to be Re-Hospitalized Within a Year 2CVS Caremark Study Finds Non-Adherent Heart Failure Patients Almost Twice as Likely to be Re-Hospitalized Within a Year 3CVS Caremark Study Finds Non-Adherent Heart Failure Patients Almost Twice as Likely to be Re-Hospitalized Within a Year 4
(Date:4/18/2014)... have made a brain-related discovery that could revolutionize ... This discovery opens up the possibility that environmental ... specific brain activity that the researchers have identified ... Journal of Neuroscience has just published a ... associate professor of psychology and his doctoral student ...
(Date:4/18/2014)... lead to potential new treatments for breaking the cycle ... Fibrosis, or scarring, is a hallmark of the disease, ... lead to serious organ damage and, in some cases, ... on findings made by Swati Bhattacharyya, PhD, research assistant ... specific protein plays in promoting fibrosis. , "Our ...
(Date:4/17/2014)... specifically associated with the risk of a difficult-to-diagnose ... of all breast cancer cases. , The largest ... invasive lobular carcinoma, gives researchers important clues to ... breast cancer, which can be missed through screening. ... journal PloS Genetics , was co-led by ...
(Date:4/17/2014)... study published today in PLOS Pathogens , children ... is common can mount an immune response to infection ... repeated bouts of high fever and illness and partially ... The findings may help researchers develop future interventions that ... parasite. , Each year, approximately 200 million cases of ...
(Date:4/17/2014)... Colo. (April 17, 2014) Two recent papers ... researcher and colleagues may help scientists develop treatments ... Yellow fever, Japanese encephalitis and other disease-causing flaviviruses. ... biochemistry and molecular genetics at the School of ... Howard Hughes Medical Institute, and colleagues recently published ...
Breaking Medicine News(10 mins):Health News:Scientists discover brain's anti-distraction system 2Health News:New clues on tissue scarring in scleroderma 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:CU researchers discover target for treating dengue fever 2
... , MONTGOMERY, Ala., ... LTCi Solutions from United of Omaha, a Mutual of Omaha company. ... products to suit producer,s sales needs - all of which offer ... on the first day of qualified need with no elimination period. ...
... , OREM, Utah, Dec. 9 LookingYourBest.com, ... Cosmetic and Plastic Surgeons , offers more than just a bold ... , The first aspect of the new LookingYourBest.com that will surely ... old, sterile layout with its pastel colors blending out to the ...
... , ARLINGTON, Va., Dec. 9 ... the Healthcare Distribution Management Association (HDMA), issued the following ... Patient Protection and Affordable Care Act, which would allow ... prescription drugs from foreign countries, as Senator Dorgan and ...
... ... , ... December 9, 2009 -- In 2008, LQ Performance Strategies predicted its core business, custom ... the economic climate deteriorated. At the same time, it recognized the opportunity to ...
... Web ... into likely employer compliance issues. , ... Minneapolis, MN (PRWEB) December 9, 2009 -- Ceridian Corporation, a ... filing and payroll outsourcing solutions, announced today it will present the first ...
... ... announce the launch of Educus ICD-9 Complete Reference – a ... the Apple iPhone, iPod touch, and Android-powered phones. The application provides ... the user can either search through all of the codes or the ...
Cached Medicine News:Health News:AIMS Benefit Solutions Offering Long-Term Care Insurance Featuring CASH-First(TM) from United of Omaha 2Health News:AIMS Benefit Solutions Offering Long-Term Care Insurance Featuring CASH-First(TM) from United of Omaha 3Health News:Your Online Resource For Plastic Surgery Information 2Health News:Statement of HDMA President and CEO John M. Gray on the Importation of Prescription Drugs 2Health News:LQ Performance Strategies Launches the LQ Solutions Vault Providing On Demand Strategic Corporate Training Products and Services 2Health News:LQ Performance Strategies Launches the LQ Solutions Vault Providing On Demand Strategic Corporate Training Products and Services 3Health News:Ceridian Web Forum to Prepare Employers for Health Care Reform 2Health News:Ceridian Web Forum to Prepare Employers for Health Care Reform 3Health News:Educus.com Launches ICD-9 app for Apple iPhone and Android Devices 2Health News:Educus.com Launches ICD-9 app for Apple iPhone and Android Devices 3
... The IsoFlex S lead's small ... ease implantation and lower the ... smaller, more tortuous vessels. Atrial ... and fixation options combine to ...
Unipolar Atrial "J" Lead...
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),...
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
Medicine Products: